However, the literature has reported that the low chemotherapy efficacy of MBC patients is mainly due to the high proportion of mucus to the total MBC cell volume, forming a large mucin pool, leading to inconsistent clinical or imaging evaluation of chemotherapy efficacy and with mucinous carcinoma pathology.37 The gene discussed is MUC5AC; the disease is mucinous adenocarcinoma.